Jingyuan Li

Jingyuan Li is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the development of compounds aimed at treating various health conditions. With a total of 4 patents, his work has the potential to impact the lives of many individuals suffering from age-related diseases and ischemia-reperfusion injuries.

Latest Patents

Jingyuan Li's latest patents include innovative methods for treating ischemia-reperfusion injuries using glutarate compounds. These methods focus on preventing, inhibiting, reducing, or treating tissue damage associated with ischemia and reperfusion injury through the use of compounds such as α-ketoglutarate. Additionally, he has developed ketobutyrate compounds and compositions aimed at addressing age-related symptoms and diseases. These methods involve treating, inhibiting, or reducing aging in subjects, as well as increasing their lifespan through the administration of ketobutyrate compounds.

Career Highlights

Jingyuan Li is affiliated with the University of California, where he conducts his research and development work. His academic background and ongoing research contribute to the advancement of medical science and the development of therapeutic solutions.

Collaborations

Some of his notable coworkers include Jing Huang and Xudong Fu, who collaborate with him on various research projects. Their combined expertise enhances the potential for innovative breakthroughs in their field.

Conclusion

Jingyuan Li's contributions to medical research through his patents and collaborations highlight his commitment to improving health outcomes. His innovative approaches to treating ischemia-reperfusion injuries and age-related diseases demonstrate the importance of continued research and development in the medical field.